“Preliminary Seroepidemiological survey of dengue infections in Pakistan, 2009-2014” by unknown
RESEARCH ARTICLE Open Access
“Preliminary Seroepidemiological survey of
dengue infections in Pakistan, 2009-2014”
Muhammad Suleman1,2, Hyeong-Woo Lee3, Syed Sohail Zahoor Zaidi2, Muhammad Masroor Alam2, Nadia Nisar2,
Uzma Bashir Aamir2, Salmaan Sharif2, Shahzad Shaukat2, Adnan Khurshid2, Mehar Angez2, Massab Umair2,
Ghulam Mujtaba2 and Rani Faryal1*
Abstract
Background: Dengue virus is the causative agent of dengue fever, a vector borne infection which causes self-
limiting to life threatening disease in humans. A sero-epidemiological study was conducted to understand the
current epidemiology of dengue virus in Pakistan which is now known as a dengue endemic country after its first
reported outbreak in 1994.
Methods: To investigate the prevalence of dengue virus in Pakistan during 2009-2014, a total of 9,493 blood
samples were screened for the detection of anti-dengue IgM antibodies using ELISA. Clinical and demographic
features available with hospital records were reviewed to ascertain mortalities related to dengue hemorrhagic shock
syndrome.
Results: Out of 9,493 samples tested, 37% (3,504) were found positive for anti-dengue IgM antibodies. Of the
seropositive cases, 73.6% (2,578/3,504) were male and 26.4% (926/3,504) were female. The highest number (382/929;
41.1%) of sero-positive cases was observed among the individuals of age group 31-40 years. The highest number of
symptomatic cases was reported in October (46%; 4,400/9,493), and the highest number of sero-positive cases
among symptomatic cases was observed in November (45.7%; 806/1,764). Mean annual patient incidence (MAPI)
during 2009-2014 in Pakistan remained 0.30 with the highest annual patient incidence (11.03) found in Islamabad.
According to the available medical case record, 472 dengue related deaths were reported during 2009-2014.
Conclusion: The data from earlier reports in Pakistan described the dengue virus incidence from limited areas of
the country. Our findings are important considering the testing of clinical samples at a larger scale covering
patients of vast geographical regions and warrants timely implementation of dengue vector surveillance and
control programs.
Trial registration number: It is an epidemiological research study, so trial registration is not required.
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Multilingual abstracts
Please see Additional file 1 for translations of the ab-
stract into six official working languages of the United
Nations.
Background
Dengue virus belongs to the genus Flavivirus within the
family Flaviviridae, and contains single stranded positive
sense RNA genome. There are four serotypes of dengue
virus DENV1-4 [1]. The primary infection caused by a sin-
gle DENV serotype is usually mild and self-limiting. The
more severe form of dengue infection is dengue
hemorrhagic fever (DHF) and dengue shock syndrome
(DSS) responsible for high morbidity and mortality [2].
Since the introduction of new dengue guidelines by World
Health Organization (WHO) in 2009, dengue is classified
into three clinical stages: dengue without warning signs;
dengue with warning signs (abdominal pain, persistent
vomiting, fluid accumulation, mucosal bleeding, lethargy,
liver enlargement, increasing hematocrit with decreasing* Correspondence: ranifaryal@gmail.com
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platelets) and severe dengue (dengue with severe plasma
leakage, severe bleeding or organ failure) [3].
Mostly Dengue virus infection is characterized by
high grade fever, headache, skin rash, muscle pain, joint
pain, and retro-orbital pain etc [4]. Typically, the sec-
ondary dengue infection with a different serotype than
the primary infection is associated with severe clinical
manifestations. Dengue virus is transmitted by mosqui-
toes mainly Aedes aegypti and to lesser extent by Aedes
albopictus. The Ae. aegypti is a day biting mosquito and
breeds in artificial as well as the natural water resources
[5]. According to WHO, more than 124 countries are at
risk of dengue virus infection and more than 100 million
cases of dengue virus infection with 25 000 estimated
deaths are reported per annum globally [6].
Pakistan reported its first outbreak of dengue
hemorrhagic fever in 1994 [7]. With several subsequent
outbreaks across country reported to date [8]. For in-
stance, during 2010–2011, dengue outbreak had oc-
curred in many districts of Punjab province including
Lahore, Sheikhupura, Gujranwala, Faisalabad, Attock
and Rawalpindi followed by 2013–2014 outbreaks in
Swat and Mansehra [9–19].
Methods
Ethical approval
This study was approved by the Internal Review Board of
National Institute of Health, (NIH) Islamabad, Pakistan.
Study design
This research study was conducted on the serum sam-
ples received at Department of Virology, NIH, Islamabad
Pakistan from different hospitals across the country dur-
ing January 2009-December 2014. The NIH Islamabad
serves as the country’s epic public health institute and
receives thousands of samples for diagnostic services and
disease outbreak investigations from all over the country.
Due to lack of an active surveillance system and poor
diagnostic capacities for hemorrhagic fever infections,
samples from suspected patients attending outpatient de-
partment and those hospitalized due to severe clinical
signs and symptoms at country hospitals are referred to
NIH for screening and confirmation.
Sample collection and laboratory diagnosis
A total of 9 493 acute phase blood samples were ana-
lyzed for the detection of anti-dengue IgM using capture
Enzyme linked immunosorbent assay (Dengue IgM
ELISA, Panbio Tech Co Brisbane, Australia). Five millili-
ters (ml) of blood sample was drawn from suspected
dengue patients attending hospitals and transported to
Department of Virology, NIH Islamabad. All blood sam-
ples were centrifuged at 3000 rpm for 5 min and serum
was stored at −70 °C until further processing.
Assay procedure for the detection of anti-dengue IgM
by ELISA
All serum samples were analyzed for the detection of
anti-dengue IgM antibodies using IgM capture ELISA
(Panbio Tech Co Brisbane, Australia) according to the
instructions provided by the manufacturer. This kit is
used for the qualitative detection of anti-dengue IgM
antibodies in patients’ serum with reported sensitivity
and specificity of 55.7–94.7% and 97–100%, respectively.
Briefly 96 well microtiter plate was precoated with
anti-human IgM antibodies. 100 μl of diluted (1:100)
serum sample and positive/negative controls were dis-
pensed to the respective wells and plate was incubated
at 37 °C for 1 h. During first incubation, anti-dengue
IgM antibodies, if present in the patient’s serum sample
were bound to anti human IgM antibodies. At the end
of incubation, all wells were six times washed with wash
buffer followed by addition of 100 μl diluted antigen to
each well and plate was incubated at 37 °C for 1 h. Dur-
ing second incubation anti-dengue horse radish peroxid-
ase conjugate was used followed by washing out the
unbound antigen/antibody complex and addition of
100 μl of TMB (3, 3′, 5, 5′-Tetramethylbenzidine) sub-
strate. The plate was finally incubated at 37 °C for
10 min. The reaction was then stopped and absorbance
(optical density) was read within 30 min using as ELISA
reader at a wavelength of 450 nm.
Interpretation of assay results
The results of test were interpreted by the calculating
cut-off value which is the average absorbance of tripli-
cate of calibrator multiplied with 0.62. Index value was
calculated by dividing sample´s optical density (O.D) by
the cut-off value. Panbio unit was calculated by multi-
plying the index value with 10. The final sample results
were interpreted as follow.
Negative Results ¼ Index value < 0:9 and Panbio unit < 9
Equivocal Results ¼ Index value 0:9‐1:1 and Panbio unit 9‐11
Positive Results ¼ Index value > 1:1 and Panbio unit > 11
Demographical analysis
Geographic distribution of dengue cases was determined
based on the information provided on patient investiga-
tion forms. The seasonal incidence was determined by
grouping all dengue cases into monthly intervals based
on the time of disease onset. Medical history records of
dengue cases available with the hospitals were also
reviewed to collect the required data including dengue
related deaths in Pakistan during 2009–2014. Data was
collected from registers, patient investigation forms as
well as a questionnaire was administered to obtain
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demographic and clinical information including the pa-
tient´s age, gender, clinical signs and symptoms, area of
residence, date of admission, date of onset, travel history
to dengue endemic areas, status at the time of discharge
and prognosis.
The annual patient incidence (API) was calculated as
the number of sero-positive (IgM+) patients per 100 000
inhabitants for each of the study sites in each year [API
= (number of sero-positive patients/population) × 100
000]. Mean Annual Patient Incidence (MAPI) was calcu-
lated as- “the sum of each year’s API in the each study
site divided by total study duration i.e.6 years [MAPI
= (sum of 6 year’s API)/6].
Data analysis
Data was analyzed using Statistical Package for Social
Science version 20 (SPSS v.20)
Results
From January 2009 to December 2014, a total of 9 493
blood samples from clinically suspected dengue cases
were received from different districts of the country and
tested for anti-dengue IgM to confirm acute dengue
virus infection.
Out of 9 493 suspected cases 3 504 (36.9%) were de-
tected positive with IgM antibodies. Among 9 493 cases,
6 858 (72.2%) were male and 2 635 (27.8%) were female.
Gender wise distribution showed that 73.6% (2 578/3
504) male and 26.4% (926/3 504) female subjects were
found IgM positive. Although the male to female ratio of
total reported cases was 3:1, positive rate of each tested
age group showed similar rates of IgM positivity be-
tween males (37.6%) and females (35.1%) (Table 1). Ac-
cording to the available medical records, 5.0% (472/
9,493) of dengue related deaths were reported during
the last six years: 2009–2014 (Table 1).
Among 3 504 IgM positive cases, the highest positive
rate (41.4%) was noticed among the individuals aged
31–40 years followed by those within 41–50 age groups
(Table 2). The majority of positive cases (96.2%; 3 359/3
504) were detected during post-monsoon season (Sep-
tember-November) with only few cases (3.8%; 133/3
504) in other months, and the highest positive rate
(45.7%) was detected in November (Table 3). Data pre-
sented in this study showed that the dengue fever cases
were not evenly distributed throughout the country. The
highest Mean Annual Patient Incidence during six years
of study (2009–2014) was reported from Islamabad
(11.03) followed by Khyber Pakhtunkhwa province,
0.45), Punjab province (0.33), Azad Jammu and Kashmir
(0.28), Sindh province (0.005), and Balochistan province
(0.003) (Fig. 1, Additional file 2: Table S1). The highest
MAPI (11.03) rate reported for Islamabad is based on
the overwhelmed number of dengue cases reported from
its different hospitals that may be attributed to the avail-
ability of adequate medical and diagnostic services in the
capital city compared to the other country hospitals.
Discussion
Majority of the clinically suspected cases in our study
were turned out as sero-negative (63.1%, 5 989/9 493)
for the dengue infection and might be hospitalized due
to several related febrile illnesses. In such situation, den-
gue incidences are mismatched between estimated and
actual number of cases and need further investigations
to rule out the possibility of other mosquito-borne
hemorrhagic infections especially chikungunya and yel-
low fever [20]. The higher incidence of infection in male
subjects may reflect their higher trend of seeking med-
ical advice and attending health units resulting in in-
creased reporting, in contrast to females who usually
prefer home remedies for cure, as evidenced in studies
from India and Nepal [21]. Being a dengue endemic
Table 1 Gender wise distribution of dengue cases and death rate during 2009–2014 in Pakistan
Year Total Male Female Number of
patients died
Death


















2009 430 136 31.6 266 72 (52.9a) 27.1b 164 64 (47.1c) 39.0d 13 3.0
2010 3131 1303 41.6 2231 942 (72.3) 42.2 900 361 (27.7) 40.1 40 1.3
2011 4459 1477 33.1 3389 1185 (80.2) 35.0 1070 292 (19.8) 27.3 362 8.1
2012 376 20 5.3 265 16 (80.0) 6.0 111 4(20.0) 3.6 0 0.0
2013 827 356 43.0 535 228 (64.0) 42.6 292 128 (36.0) 43.8 57 6.9
2014 270 212 78.5 172 135 (63.7) 78.5 98 77 (36.3) 78.6 0 0.0
Total 9493 3504 36.9 6858 2578 (73.6) 37.6 2635 926 (26.4) 35.1 472 5.0
a(Male number of positive samples/Total number of positive samples) x 100
b(Male number of positive samples/Male number of tested samples) x 100
c(Female number of positive samples/Total number of positive samples) x 100
d(Female number of positive samples/Female number of tested samples) x 100
eDeath rate = (Number of patients died / Total No. of tested samples) x 100
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country, Ae. aegypti is the most prevalent dengue vector
reported in urban areas of Pakistan such as Karachi,
Lahore, Rawalpindi, and Attock up to haripur district
but in hilly areas such as, Abbottabad, Mansehra, Swat,
and Azad Jammu and Kashmir, Ae. albopictus had also
been found during the dengue season [22]. Likewise, the
dengue positive patients residing in Pakistan exhibited a
wide geographic distribution, presenting four province
and 99 districts.
Presence of the both DENV vector mosquitoes, Ae.
aegypti and Ae. albopictus is also reported from Punjab
and Khyber Pakhtunkhwa (KPK) province [23]. The re-
cent expansion of dengue virus infection to different
parts of the country may directly be linked to climatic
and human factors such as increased rainfall, floods and
high population density that positively enhance the
vector breeding and disease transmission efficiencies.
A few published studies on dengue in Pakistan have been
reported from Karachi, Lahore and Swat [7, 8, 12, 16]
indicating repeated outbreaks in Karachi during 1994–
2008. Karachi is the largest and most populous metropol-
itan city in Pakistan and considered as one of the world’s
fastest growing cities attracting migrants from all over
Pakistan and South Asia. Despite these facts, our data
highlights Lahore as the most affected city with higher an-
nual dengue incidence rates compared to Karachi. This is
directly reflected by the smaller number of samples from
Karachi referred to NIH, Islamabad for dengue diagnostics,
owing to the comparable availability of medical and diag-
nostics services at local hospitals and medical facilities in
Karachi. Dengue virus infection was first time detected in
Lahore during 2006 following by a massive outbreak dur-
ing 2010–2011 with ensuing transmission to many country
areas. Lahore is the second largest and most populous city
in Pakistan after Karachi and its higher incidence of den-
gue infections may be linked with the massive to and fro
population movement on daily bases. Further studies are
required to investigate and rule out the true disease burden









No. of positive samples P-value
2009 2010 2011 2012 2013 2014
0–10 279 81 29.0 12 36 16 1 9 7 0.019*
11–20 1 230 429 34.9 34 171 79 6 72 67
21–30 5897 2199 37.3 61 668 1249 10 155 56
31–40 929 382 41.1 16 201 67 0 55 43
41–50 587 238 40.5 9 127 36 2 40 24
51–60 361 115 31.9 3 65 20 0 20 7
>60 210 60 28.6 1 35 10 1 5 8
Total 9493 3504 36.9 136 1303 1477 20 356 212
*= significant p-value (<0.05)
Table 3 Month wise distribution of dengue cases during 2009–2014 in Pakistan






No. of positive samples
2009 2010 2011 2012 2013 2014
January 61 1 1.6 1 0 0 0 0 0
February 38 0 0 0 0 0 0 0 0
March 49 3 6.1 0 0 0 3 0 0
April 80 5 6.3 3 1 0 1 0 0
May 117 8 6.8 3 1 2 0 1 1
June 156 20 12.8 3 0 12 1 0 4
July 122 27 22.1 2 0 2 4 2 17
August 254 79 31.1 19 1 14 0 6 39
September 2445 741 30.3 9 15 522 6 116 73
October 4 400 1812 41.2 83 700 822 1 128 78
November 1764 806 45.7 12 585 103 3 103 0
December 7 2 28.6 1 0 0 1 0 0
Total 9493 3504 36.9 136 1303 1477 20 356 212
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in Lahore, based on the demarcation between its indigen-
ous population and temporary visiting patients. Further-
more, during 2010 and 2011, 40 and 362 deaths were
reported respectively from Punjab province [9]. During
2013–2014, sporadic DENV cases were reported from sev-
eral country areas along with huge outbreak reported from
Swat and Mansehra districts in KPK province resulting in
57 deaths in Swat and adjacent areas [16].
The high mortality rate during 2011–2013 in Lahore and
Swat may point out multiple risk factors: a) these areas
were affected by flood due to heavy rainfall which provide
suitable environment for vector breeding; b) co-circulation
of multiple dengue virus serotypes in these dengue en-
demic areas leading to significant morbidity and mortality.
In Pakistan, two standard methods, ELISA and rapid
immunochromatographic test, for the diagnosis of den-
gue infection are available only at few major hospitals.
Detection of IgM antibodies by ELISA is a sensitive
marker for the identification of acute dengue virus
infection. These antibodies are detectable in 50% of pa-
tients by days 3–5 after onset of illness, increasing to
80% by day 5 and 99% by day 10. In countries like
Pakistan, the infected individuals’ visit the health facil-
ities several days after the onset of disease. Considering
these facts anti-dengue IgM ELISA may serve as a better
diagnostic tool and be the method of choice referring to
the development of IgM antibodies three to five days
after the onset of clinical signs [24].
Presently, Pakistan lacks an active surveillance system for
dengue and other arbovirus infections and solely rely on
the passive surveillance system that does not cover the en-
tire population, especially areas with poor health care set-
tings. Development of an active surveillance system would
enable health authorities to better monitor the disease inci-
dence and transmission of DENV infection to identify high
risk areas, and target dengue control activities.
There is no specific treatment available for dengue virus
infection, so patient management is mainly supportive.
Fig. 1 Geographical map of Pakistan showing districts with dengue postive cases during 2009-2014. The bar charts indicate number of DENV
positive cases in each of the four provinces and regions of Pakistan. AJK: Azad Jammu and Kashmir; KPK: Khyber Pakhtunkhwa; PB: Punjab; SD:
Sindh; BN: Baluchistan; ISB: Islamabad
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Early diagnosis and mosquito vector control is the gold
standard approach to control the dengue virus infection
[25]. Our findings emphasize that the rapid diagnostic kits
to rule out the DENV infection must be available at health
facilities of known endemic areas particularly during the
outbreak period (post-monsoon season) for the early diag-
nosis and in-time management of dengue cases [26].
Conclusions
Incessant outbreaks of dengue infection in multiple geo-
graphical areas across Pakistan highlight the urgent need
of a comprehensive surveillance and diagnostic system
in order to identify the true disease burden and pinpoint
risk factors. Further research on dengue virus infection
in Pakistan should involve rapid diagnostic facilities,
identifying circulating serotypes, studying vector popula-
tion dynamics, implementation of sustainable vector
control strategies, and public awareness on priority.
Additional files
Additional file 1: Multilingual abstracts in the six official working
languages of the United Nations. (PDF 388 kb)
Additional file 2: Table S1. Province wise, annual patient incidence of
dengue fever cases during 2009–2014 in Pakistan. (DOCX 19 kb)
Abbreviations
AJK: Azad Jammu & Kashmir; API: Annual patients’ incidence; DHF: Dengue
hemorrhagic fever; DSS: Dengue shock syndrome; ELISA: Enzyme linked
immune-sorbent assay; KPK: Khyber Pakhtunkhwa; WHO: World Health
Organization
Acknowledgements
We would like to acknowledge the support we received from the administration
and medical staff working at various hospitals in KPK Province. We especially
thankful to Dr. Bilal Bahrawar Khan, Senior Epidemiologist, Khyber Pakhtunkhwa;
Mian Sufian Mr. Umer Daraz, and Mr. Yasir Arshad from Department of Virology,
National Institute of health for their technical support in sample collection and
transportation.
Funding
The authors funded the study themselves.
Availability of data and materials
"The datasets supporting the conclusions of this article are included within
the article and its additional files."
Authors’ contributions
SSZZ, MMA, UZBA, HWL and MS conceived and designed the study. HWL, MMA,
SS, SS; MSR analyzed data and wrote the manuscript. MSR and AK performed the
laboratory tests. MA, MU and MRS collected patients’ information and performed
analysis. “All authors read and approved the final version of the manuscript″.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
“Not applicable”.
Ethics approval and consent to participate
This study was approved by the Internal Review board of National Institute
of Health, Islamabad, Pakistan
Consent to participants
A written informed consent was obtained from the patients/parents or
guardians before the collection of blood samples.
Author details
1Department of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
2Department of Virology, National Institute of Health, Islamabad, Pakistan.
3Department of Tropical Medicine and Parasitology, Inha University School of
Medicine, Incheon 22212, Republic of Korea.
Received: 22 June 2016 Accepted: 14 February 2017
References
1. Johnson BW, Russell BJ, Lanciotti RS. Serotype-specific detection of dengue
viruses in a fourplex real-time reverse transcriptase PCR assay. J Clin
Microbiol. 2005;43(10):4977–983.
2. Toan DT, Hoat LN, Hu W, Wright P, Martens P. Risk factors associated with
an outbreak of dengue fever/dengue hemorrhagic fever in Hanoi, Vietnam.
Epidemiol Infect. 2014;143:1594–8.
3. WHO. Dengue, Guidelines for diagnosis, treatment, prevention and control.
2009. http://www.who.int/tdr/publications/documents/dengue-diagnosis.
pdf?ua=1). Accessed 20 June 2016.
4. Halstead SB. Neutralization and antibody-dependent enhancement of dengue
viruses. Adv Virus Res. 2003;60:421–67.
5. Garg A, Garg AJ, Rao YK, Upadhyay GC, Sakhuja S. Prevalence of dengue
among clinically suspected febrile episodes at a Teaching Hospital in North
India. J Infect Dis Immunol. 2011;3:85–9.
6. Bhatia R, Dash AP, Sunyoto T. Changing epidemiology of dengue in South-
East Asia. WHO South-East Asia Journal of Public Health. 2013;2(1):23.
7. Jamil B, Hassan R, Zafar A, Bewley K, Chamberlain J, Mioulet V, Rowlands M,
Hewson R. Dengue Virus Serotype 3 Karachi Pakistan. Emerg Infect Dis.
2007;13:182–3.
8. Khan E, Kisat M, Khan N, Nasir A, Ayub S, Hasan R. Demographic and clinical
features of dengue fever in Pakistan from 2003-2007: a retrospective cross
sectional study. PLoS One. 2010;5(9):e12505. doi:10.1371/journal.pone.0012505.
9. Rasheed SB, Butlin RK, Boots M. A review of dengue as an emerging disease
in Pakistan. Public Health. 2013;127(1):11–7. doi:10.1016/j.puhe.2012.09.006.
10. Mahmood K, Jameel T, Aslam FH, Tahir M. Incidence of dengue haemorrhagic
fever in local population of Lahore, Pakistan. Biomedica. 2009;25:93–106.
11. Wasay M, Channa R, Jumani M, Zafar A. Changing patterns and outcome of
Dengue infection; report from a tertiary care hospital in Pakistan. J Pak Med
Assoc. 2008;58(9):488–9.
12. Fouzia TJ, Tahir AJ, Noshin WY, Abdul M, Javed A, Umer NS, Muhammad KS.
Prevalence of all four dengue serotypes confirmed by using Real Time RT-
PCR among population of Lahore Pakistan. IJAVMS. 2009;3:1–3.
13. Fatima Z, Idrees M, Bajwa MA, Tahir Z, Ullah O, Zia MQ, et al. Serotype and
genotype analysis of dengue virus by sequencing followed by phylogenetic
analysis using samples from three mini outbreaks-2007–2009 in Pakistan.
BMC Microbiol. 2011;11:200. doi:10.1186/1471-2180-11-200.
14. Koo C, Nasir A, Hapuarachchi HC, Lee KS, Hasan Z, Ng LC, et al. Evolution and
heterogeneity of multiple serotypes of Dengue virus in Pakistan, 2006–2011.
Virol J. 2013;10:275. doi:10.1186/1743-422X-10-275.
15. Rafiq MK, Afsheen A, Rasheed S. Dengue in Pakistan: Journey from a disease
free to a hyper endemic nation. J Dow Univ Health Sci Karachi. 2011;5(3):81–4.
16. Suleman M, Faryal R, Aamir UB, Alam MM, Nisar N, Sharif S, et al. Dengue
outbreak in Swat and Mansehra, Pakistan 2013; An epidemiological and
diagnostic perspective. Asian Pac J Trop Med. 2016;9(4):380–4. doi:10.1016/j.
apjtm.2016.03.010.
17. Akhtar N, Khan J, Khan A. Dengue Outbreak in Khyber Pakhtoonkhwa,
Pakistan 2013. European Acad Res. 2014;1:3842–57.
18. Khan J, Khan I, Amin I. A comprehensive entomological, serological and
molecular study of 2013 dengue outbreak of Swat, Khyber Pakhtunkhwa,
Pakistan. PLoS One. 2016;11(2):e0147416. doi:10.1371/journal.pone.0147416.
19. Anjum BF, Azmat HK, Hazrat M. Climate Change Perspective in Pakistan.
Pakistan J Meteorol. 2005;2(3):11–21.
20. Gupta E, Dar L, Kapoor G, Broor S. The changing epidemiology of dengue in
Delhi, India. Virol J. 2006;3:92.
21. Pyush T, Rashmi K, Sanjeev T, Tambe JJ, Vimala V. Descriptive epidemiology of
dengue virus transmission in Uttar Pradesh. Indian J Med Res. 1984;80:613–9.
Suleman et al. Infectious Diseases of Poverty  (2017) 6:48 Page 6 of 7
22. WHO. Country report, Vector borne diseases in Pakistan, Directorate of
Malaria Control, Government of Pakistan. Sudan: Inter country workshop
Khartoum; 2003. p. 21–3.
23. Ahmed I, Khan D, Tariq RM, Qadri SS. Population dynamics of dengue vector
Aedes aegypti L. in Thirteen Towns of Karachi, Pakistan. Int J Biotech. 2011;8:
437–43.
24. Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, et al. Evaluation of
Commercially available anti-dengue virus immunoglobulin M Tests. Emerg
Infect Dis. 2009;15:436–40.
25. Sankar SG, Dhananjeyan KJ, Paramasivean R, Thenmozhi V, Tyagi BK, Vennison
SJ. Evaluation and use of NS1 IgM antibody detection for acute dengue virus
diagnosis: report from an outbreak investigation. Clin Microbiol Infect.
2012;18:E8–E10.
26. Amin AAA, Hussain AMZ, Murshed M, Chowdhury IA, et al. Serodiagnosis of
dengue infection by haemagglutination inhibition test (HI) in suspected
cases in Chittagong, Bangladesh. Dengue Bull. 1999;23:34–8.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Suleman et al. Infectious Diseases of Poverty  (2017) 6:48 Page 7 of 7
